Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

Families 'give up legal action' against Astrazeneca after Covid vaccine blood clot deaths

Twelve families have dropped their cases, according to reports

Evening Standard · May 3, 2024

Covishield under scanner: Is Covaxin safe?

AstraZeneca's statement in court papers has sparked health concerns worldwide, especially in countries like India where COVISHIELD has been given to a large part of the population. The British pharmaceutical giant has admitted that its COVID vaccine can lead to a rare side effect called TTS or Thrombosis with Thrombocytopenia…

The Times of India · May 3, 2024

In India, all vaccine-related AEFI are routinely monitored and COVID is no exception, says health expert

All ‘Adverse Events Following Immunisation’ (AEFI) after COVID-19 vaccinations continue to be monitored, a senior official said.

The Hindu · May 2, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

"Safety is primary focus for all our vaccines": Covaxin-developer Bharat Biotech amid reports on AstraZeneca vaccine

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." Read further on Dynamite News:

Dynamite News · May 2, 2024

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

Controversy over Covishield safety reaches Supreme Court, petition seeks expert panel to study risk factors and vaccine consequences.

The Hindu · May 1, 2024

AstraZeneca's £18.7m boss Soriot bounces back as pharma giant reveals 18% sales growth

Soriot came under fire this month for his £18.7 million pay packet

Evening Standard · Apr 25, 2024

There's still plenty of shares to like on the poor old FTSE 100

City Voices: Taken together, London’s top flight mightn’t look so appealing. But that doesn’t mean that all UK stocks should be written off.

Evening Standard · Apr 15, 2024

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks with Potential Gains - Watch or Buy?

The biotech industry’s growth prospects look promising due to advanced technologies like AI, the growing popularity of tailored treatments, a rise in chronic diseases, and higher R&D spending. Let's analyze the investment prospects of biotech stocks Innoviva (INVA), Organogenesis Holdings (ORGO), and Compugen (CGEN). Read more.

StockNews.com · Apr 15, 2024

The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca

Despite rebellion, approval of £18.7m package opens door to likelihood of US-style executive pay elsewhere

The Guardian - UK · Apr 11, 2024

Astrazeneca Shareholders Approve CEO Pay Policy For 2024

AstraZeneca shareholders approve 2024 pay policy, showing confidence in CEO Soriot's leadership and company's future growth.

AstraZeneca CEO’s £18.7m pay approved despite shareholder rebellion

Third of voters reject Pascal Soriot’s deal but some say it is deserved as he had been ‘massively underpaid’

The Guardian - UK · Apr 11, 2024

FTSE 100 Live 11 April: Shares edge lower before ECB rates ca, Lok'nStore bought out by Shurgard for £378m

A new pay deal for AstraZeneca boss Pascal Soriot and the fallout from yesterday’s US inflation shock are among areas of focus for London traders.

Evening Standard · Apr 11, 2024

Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster drugs in its pipeline, this should bode well for growth at AZN.

Barchart · Mar 26, 2024

Experts say Medicaid rebate change is behind inhaler price cuts - Roll Call

Three inhaler manufacturers will cap patient copays for their inhalers at $35 a month and lower the list prices of some of those products.

Roll Call · Mar 26, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Mar 19, 2024

AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn

Britain’s biggest drugmaker’s latest acquisition will help it to develop new radiotherapy treatments

The Guardian - UK · Mar 10, 2024

When £17m isn’t enough: FTSE firms plead to pay bosses millions more

Confronted by the huge salaries on offer in the US, London boardrooms are lobbying to be allowed to make their own bosses even wealthier

The Guardian - UK · Mar 6, 2024

‘A cut-and-paste budget’: UK businesses attack lack of help from chancellor

Hospitality trade says chancellor failed to help save sector with VAT cut, while travel industry laments air duty rise

Barchart · Feb 28, 2024

2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk

While Novo Nordisk's Wegovy currently dominates the obesity treatment market, Morgan Stanley sees more upside potential for LLY and AZN stocks going forward.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Feb 27, 2024

A quiet conspiracy is afoot to give FTSE 100 executives a pay rise

As the London market’s woes are blamed on remuneration, a new US benchmark is emerging

Salon · Feb 23, 2024

Large COVID-19 vaccine study finds risks

Any pharmaceutical has risk of side effects, but a COVID infection is far more dangerous than the vaccines

The Guardian - AU · Feb 22, 2024

Two very rare Covid vaccine side-effects detected in global study of 99 million

Results confirm how uncommon known complications are as researchers confirm benefits from vaccines still ‘vastly outweigh the risks’

The Guardian - AU · Feb 21, 2024

Afternoon Update: Woolworths shares plunge; NZ MP dies after charity run; and AstraZeneca boss’s $33m paycheque

Supermarket giant’s CEO resigns unexpectedly amid increasing political pressure over record profits during cost-of-living crisis

The Guardian - UK · Feb 20, 2024

AstraZeneca boss’s £17m pay package under fire

Corporate governance thinktank questions whether Pascal Soriot’s remuneration – 1,000 times the minimum wage – is justifiable

Medical Daily · Feb 20, 2024

COVID Vaccines Linked To Slight Increase In Heart And Brain Issues: Large-Scale Study

The researchers cautioned that the study found only associations with adverse health effects and it does not prove that these issues are caused by the vaccines.

The Guardian - UK · Feb 8, 2024

Weight-loss drugs need to become cheaper, says AstraZeneca boss

Loss of muscle mass also flagged, as UK drugmaker works with China’s Eccogene on obesity and type 2 diabetes pill

1 … 13 14 15 16

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.